Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × plitidepsin × Clear all

NCT00229203 2009-12-24

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Phase 2 Completed

51 enrolled 10 charts

Multiple Myeloma, Neoplasms, Plasma Cell